Blood Sugar Targets in Surgical Intensive Care
Authors:
- Johannes RothJRJohannes Roth
- Oliver SommerfeldOSOliver Sommerfeld
- Andreas L. BirkenfeldABAndreas L. Birkenfeld
- Christoph SponholzCSChristoph Sponholz
- Ulrich A. MüllerUMUlrich A. Müller
- Christian von LoeffelholzCLChristian von Loeffelholz
- 24 September 2021
- journal article
- review article
- Published by Deutscher Arzte-Verlag GmbH in Deutsches Ärzteblatt international
- Vol. 118 (38) , 629-+
Abstract
30–80% of patients being treated in intensive care units in the perioperative period develop hyperglycemia. This stress hyperglycemia is induced and maintained by inflammatory-endocrine and iatrogenic stimuli and generally requires treatment. There is uncertainty regarding the optimal blood glucose targets for patients with diabetes mellitus. This review is based on pertinent publications retrieved by a selective search in PubMed and Google Scholar. Patients in intensive care with pre-existing diabetes do not benefit from blood sugar reduction to the same extent as metabolically healthy individuals, but they, too, are exposed to a clinically relevant risk of hypoglycemia. A therapeutic range from 4.4 to 6.1 mmol/L (79–110 mg/dL) cannot be justified for patients with diabetes mellitus. The primary therapeutic strategy in the perioperative setting should be to strictly avoid hypoglycemia. Neurotoxic effects and the promotion of wound-healing disturbances are among the adverse consequences of hyperglycemia. Meta-analyses have shown that an upper blood sugar limit of 10 mmol/L (180 mg/dL) is associated with better outcomes for diabetic patients than an upper limit of less than this value. The target range of 7.8–10 mmol/L (140–180 mg/dL) proposed by specialty societies for hospitalized patients with diabetes seems to be the best compromise at present for optimizing clinical outcomes while avoiding hypoglycemia. The method of choice for achieving this goal in intensive care medicine is the continuous intravenous administration of insulin, requirng standardized, high-quality monitoring conditions. Optimal blood sugar control for diabetic patients in intensive care meets the dual objectives of avoiding hypoglycemia while keeping the blood glucose concentration under 10 mmol/L (180 mg/dL). Nutrition therapy in accordance with the relevant guidelines is an indispensable prerequisite.Keywords
This publication has 75 references indexed in Scilit:
- Accuracy of blood-glucose measurements using glucose meters and arterial blood gas analyzers in critically ill adult patients: systematic reviewCritical Care, 2013
- Mild hypoglycemia is independently associated with increased mortality in the critically illCritical Care, 2011
- Prevalence and Clinical Outcome of Hyperglycemia in the Perioperative Period in Noncardiac SurgeryDiabetes Care, 2010
- Stress hyperglycaemiaThe Lancet, 2009
- Intensive versus Conventional Glucose Control in Critically Ill PatientsNew England Journal of Medicine, 2009
- Antecedent Hypoglycemia Impairs Autonomic Cardiovascular FunctionDiabetes, 2009
- Nonalcoholic fatty liver disease and nonalcoholic steatohepatitisHepatology, 2008
- Strict glycaemic control in patients hospitalised in a mixed medical and surgical intensive care unit: a randomised clinical trialCritical Care, 2008
- Intensive Insulin Therapy in the Medical ICUNew England Journal of Medicine, 2006
- Tight Glycemic Control in Diabetic Coronary Artery Bypass Graft Patients Improves Perioperative Outcomes and Decreases Recurrent Ischemic EventsCirculation, 2004